Author(s): Nouha Chabbar, Mohamad Ayman Awama

Email(s): nouhachabbar94@gmail.com

DOI: 10.52711/0974-360X.2024.00231   

Address: Nouha Chabbar1*, Mohamad Ayman Awama2
1Department of Biochemistry and Microbiology, Faculty of Pharmacy, Tishreen University, Lattakia, Syria.
2Department of Biochemistry and Microbiology, Faculty of Pharmacy, Tishreen University, Lattakia, Syria.
*Corresponding Author

Published In:   Volume - 17,      Issue - 4,     Year - 2024


ABSTRACT:
Hypertension (HTN) is a chronic universal health problem. It is considered an important changeable risk factor for morbidity and mortality. Diuretics are among the first-line medications for HTN treatment. Both thiazide-type diuretics and loop diuretics promote urinary loss of electrolytes such as magnesium. Magnesium has been studied for its important involvement in many physiological processes and biochemical pathways. It plays a significant role in regulating the activity of enzymes required in lipids and lipoproteins metabolism like HMG-CoA Reductase, lipoprotein lipase (LPL), and lecithin cholesterol acyl transferase (LCAT). It is well documented that dyslipidemia is a general threat to health and should be determined early to manage cardiovascular disease (CVD) and prevent its complications. The goal of the current study was to investigate the association between serum magnesium levels and lipid profile components in hypertensive patients on long-term diuretics therapy. The study was conducted on 50 adult hypertensive patients and 25 matched healthy subjects at Tishreen University Hospital (TUH) of Lattakia City in Syria. The study showed a statistically significant decrease in serum magnesium concentrations in the patients group (1.87±0.16mg/dl) versus the controls (2.40±0.41mg/dl) (P<0.05). A significant negative correlation between magnesium and triglycerides, total cholesterol, LDL cholesterol was identified, while a significant positive correlation with HDL cholesterol was found. In conclusion, this study has showed that hypomagnesemia is related to increased levels of TC, LDL-c, TG and decreased levels of HDL-c, therefore, an increased risk of dyslipidemia in hypertensive patients on diuretics.


Cite this article:
Nouha Chabbar, Mohamad Ayman Awama. A Study of the Relationship between Serum Magnesium Levels and Lipid Profile in Hypertensive patients on Diuretics. Research Journal of Pharmacy and Technology.2024; 17(4):1461-6. doi: 10.52711/0974-360X.2024.00231

Cite(Electronic):
Nouha Chabbar, Mohamad Ayman Awama. A Study of the Relationship between Serum Magnesium Levels and Lipid Profile in Hypertensive patients on Diuretics. Research Journal of Pharmacy and Technology.2024; 17(4):1461-6. doi: 10.52711/0974-360X.2024.00231   Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-4-5


REFERENCES:
1.    Oparil, S., et al., Hypertension. Nat Rev Dis Primers, 2018. 4: p. 18014. doi: 10.1038/nrdp.2018.14.
2.    T. Praveen Kumar, et al., Cardiovascular Risk Assessment in Hypertensive patients: A Perspective Observative Study.Research Journal of Pharmacy and Technology. 2021; 14(8): 4420-4. doi: 10.52711/0974-360X.2021.00767.
3.    Algburi, R., et al., Correlation of Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with serum GDF-15 in a group of hypertensive Iraqi patients. Research Journal of Pharmacy and Technology. 2022; 15. doi: 10.52711/0974-360X.2022.00580.
4.    Mrityunjay Sharma, et al., Effectiveness of Shamak Yoga on Essential Hypertension in comparison with Atenolol: A Randomized Controlled Trial. Research Journal of Pharmacy and Technology. 2021; 14(9): 4925-8. doi: 10.52711/0974-360X.2021.00856.
5.    Bin Zhou, et al., Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. The Lancet. 2017. 389(10064): 37-55. https://doi.org/10.1016/S0140-6736(16)31919-5.
6.    Iqbal, A.M. and S.F. Jamal, Essential Hypertension, in StatPearls. 2023, Treasure Island (FL).
7.    Made KrisnaAdi Jaya, et al., Effectivity Evaluation of Bisoprololas Additional Hypertension Therapy in Geriatrics with Type 2 Diabetes Mellitus while ongoing with Dual Oral Anti-Hypertension Agent: A Cohort Study. Research Journal of Pharmacy and Technology. 2021; 14(9): 4691-6. doi: 10.52711/0974-360X.2021.00815.
8.    Diksha Sharma, et al., Amlodipine And Atenolol: Combination Therapy Versus Monotherapy In Reducing Blood Pressure - A Focus On Safety And Efficacy. Research J. Pharm. and Tech, 2020; 13(6): 3007-3013. doi: 10.5958/0974-360X.2020.00532.6.
9.    James, P.A., et al., evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).Jama, 2014; 311(5): 507-20. doi: 10.1001/jama.2013.284427.
10.    Gröber, U., Magnesium and Drugs. Int J MolSci, 2019. 20(9). doi: 10.3390/ijms20092094.
11.    Găman, M.A., et al., Crosstalk of Magnesium and Serum Lipids in Dyslipidemia and Associated Disorders: A Systematic Review. Nutrients. 2021; 13(5). doi: 10.3390/nu13051411.
12.    Chen, S. and W. Cheng, Relationship Between Lipid Profiles and Hypertension: A Cross-Sectional Study of 62,957 Chinese Adult Males. Front Public Health. 2022. 10: p. 895499. doi: 10.3389/fpubh.2022.895499.
13.    Budi Santosa, et al., Effect of Biotin Treatment on the improvement of Lipid Profile and Foam Cells in Dyslipidemia rats. Research Journal of Pharmacy and Technology. 2023; 16(6): 2779-5. doi: 10.52711/0974-360X.2023.00457.
14.    Jasim, R. and T. Allwsh, Orexin A hormone and its relation to Coronary heart diseases. Research Journal of Pharmacy and Technology. 2021. doi: 10.5958/0974-360X.2021.00253.
15.    Ni KadekWarditiani, et al., Analysis of Lipid profile and Atherogenic index (AIP) in dyslipidemia rats given Ipomeabatatas tuber extract (IBTE). Research Journal of Pharmacy and Technology. 2021; 14(9): 4999-2. doi: 10.52711/0974-360X.2021.00870.
16.    SaikhuAkhmadHusen, et al., A Novel Therapeutic effects of Sargassumilicifolium Alginate and Okra (Abelmoschusesculentus) Pods extracts on Open wound healing process in Diabetic Mice. Research J. Pharm. and Tech. 2020; 13(6): 2764-2770. doi: 10.5958/0974-360X.2020.00491.6.
17.    Pelczyńska, M., et al., The Role of Magnesium in the Pathogenesis of Metabolic Disorders. Nutrients. 2022; 14(9). doi: 10.3390/nu14091714.
18.    Nartea, R., et al., The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients.Curr Issues MolBiol, 2023; 45(4): 3146-3167. doi: 10.3390/cimb45040205.
19.    Schwalfenberg, G.K. and S.J. Genuis, The Importance of Magnesium in Clinical Healthcare.Scientifica (Cairo). 2017: 4179326. doi: 10.1155/2017/4179326.
20.    Andrea, R. and S.S. Mildred, Comparison of Mechanism and Functional Effects of Magnesium and Statin Pharmaceuticals. Journal of the American College of Nutrition. 2004; 23(5): 501S-505S. doi: 10.1080/07315724.2004.10719389.
21.    Kisters, K. and U. Gröber, Magnesium and thiazide diuretics. Magnes Res. 2018; 31(4): 143-145. 10.1684/mrh.2019.0447.
22.    Curry, J.N. and A.S.L. Yu, Magnesium Handling in the Kidney. Adv Chronic Kidney Dis. 2018; 25(3): 236-243. 10.1053/j.ackd.2018.01.003.
23.    Swaminathan, R., Magnesium metabolism and its disorders. The Clinical biochemist. Reviews. 2003; 24(2): 47-66. PMID: 18568054.
24.    Ismail, A.A.A., et al., Chronic magnesium deficiency and human disease; time for reappraisal? QJM: An International Journal of Medicine. 2017; 111(11): 759-763. doi: 10.1093/qjmed/hcx186.
25.    Witkowski, M., et al., Methods of assessment of magnesium status in humans: a systematic review. Magnesium Research. 2011; 24(4): 163-180. https://doi.org/10.1684/mrh.2011.0292.
26.    Arnaud, M.J., Update on the assessment of magnesium status. British Journal of Nutrition. 2008; 99(S3): S24-S36. doi: 10.1017/S000711450800682X.
27.    Van Laecke, S. Hypomagnesemia and hypermagnesemia.Acta Clin Belg. 2019; 74(1): 41-47. doi: 10.1080/17843286.2018.1516173.
28.    Fiorentini, D., et al., Magnesium: Biochemistry, Nutrition, Detection, and Social Impact of Diseases Linked to Its Deficiency. Nutrients. 2021; 13(4): 1136. doi: 10.3390/nu13041136.
29.    Nielsen, F.H. and L.A. Johnson, Data from Controlled Metabolic Ward Studies Provide Guidance for the Determination of Status Indicators and Dietary Requirements for Magnesium. Biol Trace Elem Res. 2017; 177(1): 43-52. doi: 10.1007/s12011-016-0873-2.
30.    Mya MyaThwin, et al., Fluctuations in Serum magnesium and Systemic Arterial Blood Pressures during the Menstrual Cycle in young reproductive women. Research Journal of Pharmacy and Technology. 2022; 15(2): 751-6. doi: 10.52711/0974-360X.2022.00125.
31.    Gröber, U., et al., Magnesium in Prevention and Therapy. Nutrients. 2015; 7(9): 8199-226. doi: 10.3390/nu7095388.
32.    Kieboom, B.C.T., et al., Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population. Pharmacoepidemiol Drug Saf. 2018; 27(11): 1166-1173. doi: 10.1002/pds.4636.
33.    Nijenhuis, T., et al., Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest. 2005; 115(6): 1651-8. doi: 10.1172/jci24134.
34.    Dai, L.J., et al., Magnesium transport in the renal distal convoluted tubule.Physiol Rev. 2001; 81(1): 51-84. doi: 10.1152/physrev.2001.81.1.51.
35.    Maktabi, M., et al., The effects of magnesium and vitamin E co-supplementation on parameters of glucose homeostasis and lipid profiles in patients with gestational diabetes. Lipids Health Dis, 2018; 17(1): 163. doi: 10.1186/s12944-018-0814-5.
36.    Dibaba, D.T., et al., Dietary magnesium intake and risk of metabolic syndrome: a meta-analysis. Diabet Med. 2014; 31(11): 1301-9. doi: 10.1111/dme.12537.
37.    Mahalle, N., et al., Is hypomagnesaemia a coronary risk factor among Indians with coronary artery disease? J Cardiovasc Dis Res. 2012; 3(4): 280-6. doi: 10.4103/0975-3583.102698.
38.    Liu, A., et al., High serum concentration of selenium, but not calcium, cobalt, copper, iron, and magnesium, increased the risk of both hyperglycemia and dyslipidemia in adults: A health examination center based cross-sectional study. J Trace Elem Med Biol. 2020; 59: 126470. doi: 10.1016/j.jtemb.2020.126470.
39.    Jin, H. and J. Nicodemus-Johnson, Gender and Age Stratified Analyses of Nutrient and Dietary Pattern Associations with Circulating Lipid Levels Identify Novel Gender and Age-Specific Correlations. Nutrients. 2018; 10(11). doi: 10.3390/nu10111760.
40.    Kim, D.S., et al., Effects of dietary components on high-density lipoprotein measures in a cohort of 1,566 participants. Nutrition & Metabolism. 2014; 11(1): 44. doi: 10.1186/1743-7075-11-44.
41.    Rodríguez-Moran, M. and F. Guerrero-Romero, Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial. Arch Med Res. 2014; 45(5): 388-93. doi: 10.1016/j.arcmed.2014.05.003.
42.    Randell, E.W., et al., Relationship between serum magnesium values, lipids and anthropometric risk factors. Atherosclerosis. 2008; 196(1): 413-419. doi: 10.1016/j.atherosclerosis.2006.11.024.
43.    Barragán, R., et al., Influence of Demographic and Lifestyle Variables on Plasma Magnesium Concentrations and Their Associations with Cardiovascular Risk Factors in a Mediterranean Population. Nutrients. 2020; 12(4): doi:10.3390/nu12041018.
44.    Sarikaya, M., et al., The Prevalence of Hypomagnesemia in Essential Hypertensive Patients. International Journal of Science and Research. 2015: 438.
45.    Razzaque, M.S., Magnesium: Are We Consuming Enough? Nutrients. 2018; 10(12). doi: 10.3390/nu10121863.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available